TABLE 6-1 Summary of Opportunities for Patient or Public Input in Selected Technology Coverage Processes in Different Regions

Identification of Technologies Selection of Technologies for Assessment Undertaking of HTAa Review of HTA Results and Formulation of Recommendations Implementation of Recommendations and Decisions Dissemination of Decisions and HTA Findings
Adviser and/or Decision Maker Patients Public Patients Public Patients Public Patients Public Patients Public Patients Public
National Level
USAb Yes No Yes Yes Yes Yes Yes Yes Yes Yes N/A N/A
CMS (decisions)
CMS Medicare
Evidence
Development and
Coverage Advisory
Committee
Patients and/or
carers may refer
technologies for
assessment
Anyone may
provide additional
information and/or
comment on potential
technology topics
identified by CMS
staff
Anyone may submit
information to group
preparing HTA
Anyone may register
to present to the
committee
Anyone may appeal
recommendations
No information found
State Level
Oregon, USAc Yes Yes No No Yes Yes Yes Yes No No No No
State of Oregon Health
Resources Commission
(recommendations)
Technologies may be
referred by anyone
N/A Anyone may submit
information to group
preparing HTA
Anyone may register
to present to the
committee

Anyone may provide
comments on report and
draft recommendations

Committee meetings in
public
N/A N/A
Washington, USAd
• Washington State
Healthcare Authority
(decisions)
• Washington State
Healthcare Authority
Health Technology
Clinical Committee
Yes
Technologies may be
referred by anyone
Yes No
N/A
No Yes
Anyone may submit
information to group
preparing HTA
Yes Yes
Anyone may provide
comments on report and
draft recommendations
Yes No
N/A
No No
N/A
No

a CMS = Centers for Medicare & Medicaid Services; HTA = health technology assessment.

b Chalkidou et al., 2009; CMS, 2003, 2006a,b,c; ISPOR, 2011; Washington State Health Care Authority, 2007a.

c Oregon Health Resources Commission, 1994, 2006.

d Washington State Health Care Authority, 2007a,b,c, 2008.

SOURCE: Adapted from Menon and Stafinski (2011) in Expert Review of Pharmacoeconomics & Outcomes Research, February 2011, Vol. 11, No. 1, Pages 75-89 with permission of Expert Reviews Ltd.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement